A detailed history of Segall Bryant & Hamill, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Segall Bryant & Hamill, LLC holds 477,880 shares of TECH stock, worth $35 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
477,880
Previous 405,869 17.74%
Holding current value
$35 Million
Previous $29.1 Million 31.32%
% of portfolio
0.53%
Previous 0.52%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$70.96 - $82.35 $5.11 Million - $5.93 Million
72,011 Added 17.74%
477,880 $38.2 Million
Q2 2024

Aug 14, 2024

BUY
$62.12 - $84.15 $7.78 Million - $10.5 Million
125,299 Added 44.66%
405,869 $29.1 Million
Q1 2024

May 15, 2024

SELL
$65.98 - $77.09 $774,803 - $905,267
-11,743 Reduced 4.02%
280,570 $19.7 Million
Q4 2023

Feb 14, 2024

SELL
$52.83 - $78.22 $30.5 Million - $45.1 Million
-576,987 Reduced 66.37%
292,313 $22.6 Million
Q3 2023

Nov 09, 2023

SELL
$67.52 - $89.42 $4.76 Million - $6.31 Million
-70,546 Reduced 7.51%
869,300 $59.2 Million
Q2 2023

Aug 11, 2023

SELL
$73.76 - $85.98 $1.35 Million - $1.58 Million
-18,361 Reduced 1.92%
939,846 $76.7 Million
Q1 2023

May 15, 2023

BUY
$71.62 - $86.62 $170,885 - $206,675
2,386 Added 0.25%
958,207 $71.1 Million
Q4 2022

Feb 14, 2023

BUY
$80.67 - $352.29 $77.1 Million - $337 Million
955,821 New
955,821 $79.2 Million
Q3 2022

Nov 14, 2022

BUY
$282.54 - $391.85 $67.7 Million - $93.9 Million
239,542 New
239,542 $68 Million
Q2 2022

Aug 15, 2022

SELL
$322.67 - $449.65 $2.67 Million - $3.72 Million
-8,280 Reduced 3.67%
217,241 $75.3 Million
Q1 2022

May 13, 2022

BUY
$353.85 - $487.79 $1.47 Million - $2.02 Million
4,145 Added 1.87%
225,521 $97.7 Million
Q4 2021

Feb 14, 2022

SELL
$456.15 - $525.06 $2.9 Million - $3.34 Million
-6,357 Reduced 2.79%
221,376 $115 Million
Q3 2021

Nov 03, 2021

SELL
$444.87 - $538.88 $3.64 Million - $4.4 Million
-8,174 Reduced 3.46%
227,733 $110 Million
Q2 2021

Aug 12, 2021

SELL
$387.35 - $450.26 $1.87 Million - $2.17 Million
-4,829 Reduced 2.01%
235,907 $106 Million
Q1 2021

May 13, 2021

SELL
$314.62 - $411.0 $6.82 Million - $8.9 Million
-21,666 Reduced 8.26%
240,736 $91.9 Million
Q4 2020

Feb 12, 2021

BUY
$246.9 - $321.87 $3.17 Million - $4.14 Million
12,847 Added 5.15%
262,402 $83.3 Million
Q3 2020

Nov 13, 2020

BUY
$232.22 - $282.96 $4.25 Million - $5.18 Million
18,323 Added 7.92%
249,555 $61.8 Million
Q2 2020

Aug 14, 2020

SELL
$185.43 - $279.56 $3.81 Million - $5.75 Million
-20,563 Reduced 8.17%
231,232 $61.1 Million
Q1 2020

May 14, 2020

SELL
$161.17 - $221.51 $1.12 Million - $1.54 Million
-6,937 Reduced 2.68%
251,795 $47.7 Million
Q4 2019

Feb 11, 2020

SELL
$189.68 - $222.09 $3.9 Million - $4.56 Million
-20,552 Reduced 7.36%
258,732 $56.8 Million
Q3 2019

Nov 12, 2019

BUY
$183.56 - $216.72 $1.52 Million - $1.8 Million
8,290 Added 3.06%
279,284 $54.6 Million
Q2 2019

Aug 14, 2019

SELL
$188.72 - $215.43 $627,116 - $715,873
-3,323 Reduced 1.21%
270,994 $0
Q1 2019

May 15, 2019

BUY
$136.09 - $200.44 $1.21 Million - $1.78 Million
8,894 Added 3.35%
274,317 $0
Q4 2018

Feb 15, 2019

SELL
$132.75 - $203.8 $1.36 Million - $2.1 Million
-10,282 Reduced 3.73%
265,423 $38.4 Million
Q3 2018

Nov 14, 2018

SELL
$147.44 - $204.11 $13.1 Million - $18.1 Million
-88,634 Reduced 24.33%
275,705 $0
Q2 2018

Aug 08, 2018

BUY
$144.9 - $165.58 $7.77 Million - $8.88 Million
53,657 Added 17.27%
364,339 $0
Q1 2018

May 16, 2018

SELL
$131.46 - $151.04 $4.76 Million - $5.47 Million
-36,183 Reduced 10.43%
310,682 $0
Q4 2017

Feb 15, 2018

SELL
$121.17 - $134.75 $13.4 Million - $14.9 Million
-110,352 Reduced 24.14%
346,865 $0
Q3 2017

Nov 14, 2017

BUY
$113.59 - $123.78 $51.9 Million - $56.6 Million
457,217
457,217 $0

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.87B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Segall Bryant & Hamill, LLC Portfolio

Follow Segall Bryant & Hamill, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.